» Articles » PMID: 28124587

Alzheimer's Disease and Chinese Medicine As a Useful Alternative Intervention Tool: A Mini-Review

Overview
Specialty Neurology
Date 2017 Jan 27
PMID 28124587
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Alzheimer´s disease (AD) is a serious and complex neurodegenerative disease. Currently, there are about 44 million people suffering from AD all over the world and this number is expected to rapidly grow due to demographic changes. The disease can be treated both pharmacologically and non-pharmacologically. Unfortunately, it cannot be cured yet. Nevertheless, the drugs for the treatment of AD are quite expensive, have different side effects and only delay symptoms of this disease. Therefore researchers suggest the use of various non-pharmacological therapies. Apart from relatively popular in western world such as physical activities, cognitive training or healthy diet, Chinese medicine starts to be practiced in Europe.

Objective: The purpose of this mini-review is to discuss the concept of Chinese medicine and explore its most common and effective forms in the treatment of AD.

Methods: This was done by conducting a literature search in the world´s acknowledged databases such as Web of Science, Scopus, PubMed and Springer.

Results: Five randomized controlled clinical trial studies were analyzed and their findings were discussed.

Conclusion: The authors of this mini-review list the key benefits (e.g., positive results of the reviewed randomized clinical trials studies for the improvement of cognitive decline in AD) and limitations (e.g., low awareness of benefits of TCM in Europe) of Chinese medicine therapy for the treatment of AD.

Citing Articles

Effectiveness and Safety of Bu Shen Kai Qiao Fang in the Treatment of Alzheimer's Disease: Study Protocol for a Multicenter, Prospective, Real-World Clinical Trial.

Xu Z, Li O, Liang Y, Wu Z, Xu J, Wang L Int J Gen Med. 2023; 16:2573-2583.

PMID: 37351010 PMC: 10284162. DOI: 10.2147/IJGM.S418700.


Catalpol Mitigates Alzheimer's Disease Progression by Promoting the Expression of Neural Stem Cell Exosomes Released miR-138-5p.

Meng S, Chen H, Deng C, Meng Z Neurotox Res. 2023; 41(1):41-56.

PMID: 36595161 PMC: 9944361. DOI: 10.1007/s12640-022-00626-z.


Investigation of the "Nose-to-Brain" Pathways in Intranasal HupA Nanoemulsions and Evaluation of Their in vivo Pharmacokinetics and Brain-Targeting Ability.

Jiang Y, Jiang Y, Ding Z, Yu Q Int J Nanomedicine. 2022; 17:3443-3456.

PMID: 35959279 PMC: 9359405. DOI: 10.2147/IJN.S369978.


Gao-Zi-Yao improves learning and memory function in old spontaneous hypertensive rats.

Han M, Jiang W, Jiang Y, Wang L, Xue R, Zhang G BMC Complement Med Ther. 2022; 22(1):147.

PMID: 35643519 PMC: 9148521. DOI: 10.1186/s12906-022-03630-0.


A novel polysaccharide from exerts anti-inflammatory effects STAT3 signal pathway.

Li Q, Li Q, Hao Z, Zheng X, He W RSC Adv. 2022; 8(46):26371-26376.

PMID: 35541964 PMC: 9083078. DOI: 10.1039/c8ra02923g.